A detailed history of Petrus Trust Company, Lta transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 109,228 shares of HCAT stock, worth $848,701. This represents 0.07% of its overall portfolio holdings.

Number of Shares
109,228
Previous 148,235 26.31%
Holding current value
$848,701
Previous $1.12 Million 37.54%
% of portfolio
0.07%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.53 - $7.28 $215,708 - $283,970
-39,007 Reduced 26.31%
109,228 $697,000
Q1 2024

May 15, 2024

BUY
$7.44 - $11.21 $470,557 - $708,998
63,247 Added 74.42%
148,235 $1.12 Million
Q4 2023

Feb 14, 2024

BUY
$6.71 - $10.16 $372,834 - $564,530
55,564 Added 188.84%
84,988 $786,000
Q3 2023

Nov 14, 2023

BUY
$9.35 - $14.32 $9,424 - $14,434
1,008 Added 3.55%
29,424 $297,000
Q1 2023

May 15, 2023

BUY
$10.23 - $14.76 $290,695 - $419,420
28,416 New
28,416 $331,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.